Centro de Ciências da Saúde, Laboratório de Bioquímica do Exercício (BioEx), Programa de Pós-Graduação em Farmacologia - Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil.
Neuropharmacology. 2013 Apr;67:455-64. doi: 10.1016/j.neuropharm.2012.10.022. Epub 2012 Dec 3.
Administration of the compound triterpene 3β, 6β, 16β-trihidroxilup-20(29)-ene (TTHL) resulted in antinociceptive activity in several pain models in mice. Because pain and epilepsy have common mechanisms, and several anticonvulsants are clinically used to treat painful disorders, we investigated the anticonvulsant potential of TTHL. Behavioral and electrographic recordings revealed that pretreatment with TTHL (30 mg/kg; i.g.) increased the latencies to the first clonic seizure to the tonic-clonic and reduced the duration of the generalized seizures induced by the GABA(A) receptor antagonist PTZ (80 g; i.p.). The TTHL pretreatment also protected against PTZ-induced deleterious effects, as characterized by protein carbonylation, lipid peroxidation, [(3)H] glutamate uptake and the inhibition of Na(+),K(+)-ATPase (subunits α(1) and α(2)/α(3)). Although TTHL did not exhibit DPPH, ABTS radical scavenging activity per se and does not alter the binding of [(3)H]flunitrazepam to the benzodiazepinic site of the GABA(A) receptor, this compound was effective in preventing behavioral and EEG seizures, as well as the inhibition of Na(+),K(+)-ATPase induced by ouabain. These results suggest that the protection against PTZ-induced seizures elicited by TTHL is due to Na(+),K(+)-ATPase activity maintenance. In fact, experiments in homogenates of the cerebral cortex revealed that PTZ (10 mM) reduced Na(+),K(+)-ATPase activity and that previous incubation with TTHL (10 μM) protected against this inhibition. Collectively, these data indicate that the protection exerted by TTHL in this model of convulsion is not related to antioxidant activity or GABAergic activity. However, these results demonstrated that the effective protection of Na(+),K(+)-ATPase elicited by this compound protects against the damage due to neuronal excitability and oxidation that is induced by PTZ.
化合物三萜 3β, 6β, 16β-三羟基齐墩果酸(TTHL)的给药导致了几种小鼠疼痛模型中的镇痛活性。因为疼痛和癫痫有共同的机制,并且几种抗惊厥药临床上用于治疗疼痛障碍,所以我们研究了 TTHL 的抗惊厥潜力。行为和脑电图记录显示,TTHL(30mg/kg;ig)预处理增加了 GABA(A)受体拮抗剂 PTZ(80μg;ip)诱导的强直-阵挛和全身发作的首次阵挛发作的潜伏期,并减少了发作时间。TTHL 预处理还防止了 PTZ 诱导的有害影响,表现为蛋白羰基化、脂质过氧化、[(3)H]谷氨酸摄取和 Na(+),K(+)-ATP 酶(亚基 α(1)和 α(2)/α(3))的抑制。尽管 TTHL 本身不具有 DPPH、ABTS 自由基清除活性,也不改变 [(3)H]氟硝西泮与 GABA(A)受体苯二氮卓结合位点的结合,但该化合物能有效预防行为和 EEG 发作,以及抑制由哇巴因诱导的 Na(+),K(+)-ATP 酶。这些结果表明,TTHL 对 PTZ 诱导的发作的保护作用是由于 Na(+),K(+)-ATP 酶活性的维持。事实上,在大脑皮层匀浆的实验中发现,PTZ(10mM)降低了 Na(+),K(+)-ATP 酶的活性,而 TTHL(10μM)的预先孵育则可以防止这种抑制。总的来说,这些数据表明,TTHL 在这种惊厥模型中发挥的保护作用与抗氧化活性或 GABA 能活性无关。然而,这些结果表明,这种化合物对 Na(+),K(+)-ATP 酶的有效保护可以防止神经元兴奋性和氧化引起的 PTZ 损伤。